Alpha DNA Investment Management’s PACCAR PCAR Stock Holding History

Alpha DNA Investment Management’s Portfolio PCAR Stock Details PCAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7,267	Closed	-$756K	–	125
2024 Q4	$756K	Sell	7,267 -1,494	-17%	-$164K	0.29%	79
2024 Q3	$865K	Buy	8,761 +3,930	+81%	+$384K	0.32%	68
2024 Q2	$497K	Sell	4,831 -1,549	-24%	-$171K	0.19%	106
2024 Q1	$790K	Buy	+6,380	New	+$686K	0.29%	76
2023 Q3	–	Sell	-13,912	Closed	-$1.16M	–	209
2023 Q2	$1.16M	Sell	13,912 -6,284	-31%	-$465K	0.39%	41
2023 Q1	$1.48M	Sell	20,196 -875	-4%	-$62.6K	0.44%	37
2022 Q4	$1.39M	Buy	+21,071	New	+$1.38M	0.49%	43
2021 Q2	–	Sell	-375	Closed	-$23K	–	480
2021 Q1	$23K	Hold	375	–	–	0.03%	240
2020 Q4	$21K	Buy	+375	New	+$22K	0.02%	257

Other funds holding PCAR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alpha DNA Investment Management's PCAR Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of PACCAR (PCAR) in Q1 2025, closing a stake of 7,267 shares — an estimated $756K sold.

Alpha DNA Investment Management first reported a position in PCAR in Q4 2020 and held it in 9 quarters. The position peaked at $1.48M in Q1 2023. 999 funds tracked by Wall St. Rank hold PCAR as of Q1 2025.

Alpha DNA Investment Management reported no remaining PACCAR position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 7,267 PACCAR shares in Q1 2025, an estimated $756K.
Alpha DNA Investment Management first reported a position in PACCAR in Q4 2020 and held it in 9 quarters.
Alpha DNA Investment Management's PACCAR position peaked at $1.48M in Q1 2023.
999 funds tracked by Wall St. Rank held PACCAR as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.